Emisphere Announces Multi-Product Research Collaboration Agreement with Roche

Emisphere Technologies, Inc. has announced that it has entered into a multi-product research collaboration agreement with Roche to explore the use of Emisphere's eligen^® technology in feasibility studies for oral formulations of a number of Roche molecules.

Roche will fund the research, which will be conducted at both Roche and Emisphere.

Michael M. Goldberg, M.D., Chairman and Chief Executive Officer, Emisphere Technologies, Inc., commented, "Establishing a research collaboration agreement with Roche to investigate the application of our technology on multiple compounds demonstrates the value Emisphere brings to the product development process."

"Roche has been working with Emisphere for a number of years and this new agreement further strengthens the relationship between our two companies."